Startseite>>Signaling Pathways>> Proteases>> Ser/Thr Protease>>Cetraxate hydrochloride

Cetraxate hydrochloride

Katalog-Nr.GC62175

Cetraxathydrochlorid (DV-1006), ein oral wirksames Mittel gegen GeschwÜre mit schleimhautschÜtzender Wirkung, kann fÜr die Erforschung von MagengeschwÜren verwendet werden.

Products are for research use only. Not for human use. We do not sell to patients.

Cetraxate hydrochloride Chemische Struktur

Cas No.: 27724-96-5

Größe Preis Lagerbestand Menge
5 mg
65,00 $
Auf Lager
10 mg
117,00 $
Auf Lager
25 mg
247,00 $
Auf Lager
50 mg
405,00 $
Auf Lager
100 mg
648,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Cetraxate hydrochloride (DV-1006), an orally active anti-ulcer agent with mucosal protective effects, can be used for gastric ulcers research[1]. Cetraxate hydrochloride is a potent acrosomal proteinase acrosin inhibitor with a Ki and an IC50 of 0.94 μM and 3.3 μM, respectively[2].

[1]. Fumihiko Katagiri, et al. Cetraxate raises levels of calcitonin gene-related peptide and substance P in human plasma. J Pharm Pharmacol. 2004 Apr;56(4):557-61.
[2]. H Sumi, et al. Inhibitors of the acrosomal proteinase acrosin: human urinary trypsin inhibitor (UTI) and 4-(2-carboxyethyl) phenyl trans 4-aminomethylcyclohexanecarboxylate hydrochloride (DV-1006). Experientia. 1980 Sep 15;36(9):1103-4.

Bewertungen

Review for Cetraxate hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cetraxate hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.